1. Factors determining the sensitivity to proteasome inhibitors of multiple myeloma cells
   Marta Pelon et al, 2024, Frontiers in Pharmacology CrossRef
2. Immunoediting in acute myeloid leukemia: Reappraising T cell exhaustion and the aberrant antigen processing machinery in leukemogenesis
   Ching-Yun Wang et al, 2024, Heliyon CrossRef
3. Flow cytometry in acute myeloid leukemia and detection of minimal residual disease
   Qihui Cai et al, 2025, Clinica Chimica Acta CrossRef
4. Vemurafenib induces senescence in acute myeloid leukemia and myelodysplastic syndrome by activating the HIPPO signaling pathway: implications for potential targeted therapy
   Qiao Zhou et al, 2024, Biology Direct CrossRef